Hvor bivirkningsincidensen var forskellig mellem Paxene og andre paclitaxel kliniske undersøgelser, vises den oftest forekommende incidens.
Where event incidence differed between Paxene and other paclitaxel clinical studies, the most frequent incidence is presented.